• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

ZeOmega Acquires HealthUnity To Close Gaps in Interoperability

by Jasmine Pennic 03/24/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

zeomega-2015

On Monday, population health management provider ZeOmega announced the acquisition of HealthUnity, a provider of interoperability solutions that enable providers, payers and public health organizations to streamline the secure exchange of patient data across disparate systems. HealthUnity offerings also include private and public HIE, master person index, referral management and patient consent to integrated delivery networks (IDNs), health systems, group practices and state collaboratives. Financial terms of the acquisition were not disclosed. 

In an interview with HIStalk, Nandini Rangaswamy, co-founder, EVP, and chief strategy officer of ZeOmega stated: 

Nandini_ZeOmega
Nandini Rangaswamy

“Hundreds of EMR, analytics, and HIE companies are trying to make a name in population health management, but they’re viewing PHM too narrowly. Competitors have some ingredients, but ZeOmega has an end-to-end strategy, anchored by what we call five pillars of PHM that includes the ability to drive an effective PHM program design and governance, aggregate data on the patient across the care continuum and all care settings, derive actionable insights from this data, enable effective real-time care coordination with those insights, and the ability to educate, engage and empower patients.”

“Acquiring HealthUnity lets ZeOmega close gaps in interoperability and patient resolution to become the industry’s first end-to-end PHM solution. So it’s my perspective that no other company can compete with our comprehensive offerings. That said, we will be competing with other companies who only have solutions for part of the care continuum. We’re so focused on doing what’s right for our clients, most of all eliminating information barriers to achieve real value-based care, so we probably will end up collaborating with come competitors’ solutions. We won’t shy away from that if it means enhancing value for our clients,” said Rangaswamy.

The acquisition of Health Unity will help ZeOmega create a powerful, rapidly deployable PHM infrastructure that payers and providers alike can use to drive value-based care, not only within their organization, but also within their communities. The combined company is uniquely positioned to help providers and payers share clinical and claims analytics with the goal of improving outcomes while reducing the cost of healthcare in the evolving value-based care environment.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |